A Clinical study on AMIRDHAVALLI CHOORANAM in the management of Madhumegam(Diabetes Mellitus)

A Prospective Open Labelled Phase II Non-Randomized Clinical Trial on AMIRDHAVALLI CHOORANAM in the Management of Madhumega Noi(Diabetes Mellitus)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031369

Enrollment

Registered

2021-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Amirdhavalli Chooranam: 50mg/kg/BW/twice a day( orally)A/F 45 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Type II diabetes mellitus,previously diagnosed diabetic patients which are uncontrolled or poorly controlled for more than 2 years duration of the illness Even if the patient is having any one among the three: FBS-126mg/dl to 250mg/dl PPBS-200mg/dl to 350mg/dl HbA1C-6.5-10 Patients with symptom of polyuria, polydipsia,polyphagia,asthenia,nocturia,obesity,numbness,tingling sensation,mood changes and irritability.

Exclusion criteria

Exclusion criteria: Age below 35 yrs above 60 yrs Type I DM Gestational DM Diabetes insipidus Pregnancy/lactating mother Chronic kidney disease Chronic liver disease Ischemic heart disease

Design outcomes

Primary

Measure	Time frame
To develop evidence support for the effect of AMIRDHAVALLI CHOORANAM in the management of Madhumega Noi(Diabetes Mellitus)Timepoint: 45 days	—

Secondary

Measure	Time frame
To collect various siddha literatures and modern journals To evaluate Physio chemical,Phyto chemical,Bio-chemical analysis To study the anti-microbial activity for selected micro organisms To evaluate Pharmacological activity,Safety profile for acute and subacute toxicity of trial drug To evaluate the efficacy of Amirdhavalli Chooranam on Madhumegam by the Bio-Statistical analysisTimepoint: 45 days	—

Measure

Time frame

To collect various siddha literatures and modern journals To evaluate Physio chemical,Phyto chemical,Bio-chemical analysis To study the anti-microbial activity for selected micro organisms To evaluate Pharmacological activity,Safety profile for acute and subacute toxicity of trial drug To evaluate the efficacy of Amirdhavalli Chooranam on Madhumegam by the Bio-Statistical analysisTimepoint: 45 days

—

Countries

India

Contacts

Public ContactDrAManoharan MD s Ph D

Government Siddha Medical College and Hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026